TriNetX’s Post

From manual systems to today's cutting-edge technology, PV databases play a vital role in ensuring drug safety. The digital revolution sped up reporting and analysis, and now big data and AI are uncovering deeper insights. Looking ahead, collaboration, standardized reporting, and patient involvement promise a safer, more connected future. Learn more here- https://lnkd.in/dRu9pfSN Let's keep advancing together! #Pharmacovigilance #DrugSafety #HealthcareEvolution

With regulatory bodies raising the bar and #AI unlocking new dimensions, #pharmacovigilence experts can no longer afford to delay their real-world data strategies. Embracing #RWD isn’t just about compliance—it's about proactive drug safety, deeper insights, and solidifying a place in the data-driven #healthcare landscape. Discover the power of a robust RWD strategy in our latest blog. https://ow.ly/k2FW50U7OjH

RAPS LEARNING INSIGHT WITH INDUSTRY EXPERTS Leveraging Today’s Technology to Accelerate Submissions: Real Life Examples and Lessons Learned 🚀 As the drug development industry pushes to accelerate submission timelines and improve patient access to healthcare, regulatory professionals face increasing pressure to leverage technology for faster results. In a recent webinar, #HeatherGraham, VP of Regulatory Science and Medical Affairs at Certara, led an insightful panel discussion with industry experts #AngelaRussell, #AlizaNathoo, and #MattRenda. The panel explored the current technology landscape in regulatory affairs, how these tools can be harnessed to drive high-quality, fit-for-purpose submissions, and the importance of effective change management when implementing technology across organizations. #RAPS #AI #RegulatoryAffairs #DrugDevelopment #HealthcareTechnology #Certara #InnovationInRegulatory

With DF Literature Monitor, review only relevant articles and save time. Experience efficient and precise AI-powered data extraction tailored to your products.   👉 Swipe through our carousel to discover: • Multi-source data ingestion • Automated filtering and categorization of articles • Customized review workflows for your team Ready to streamline your literature surveillance process? Visit Datafoundry AI to learn more! https://datafoundry.ai/ #Pharmacovigilance | #literaturesurveillance | #literaturemonitoring | #SafetyVigilance | #DFLiteratureMonitor | #ArticleDeduplication | #AIinHealthcare | #E2B | #datafoundry | #healthcare | #lifescience | #LiteratureMonitoringsolution | #LiteratureMonitor

 👀ICYMI👀 Our latest Q&A with Pharma's Almanac dug into how PrimeVigilance navigates the evolving pharmacovigilance landscape with cutting-edge solutions and unparalleled expertise.   PrimeVigilance is not just revolutionizing adverse event detection and reporting. We're setting new global standards and playing a crucial role in safeguarding public health internationally.   Read more about how we're leading the charge in addressing industry needs within an increasingly complex healthcare system, demonstrating our adaptability and commitment to excellence: https://lnkd.in/epwHkEPy #PrimeVigilance #Pharmacovigilance #AI #AdverseEventReporting

Drug development is a document-intensive process, with strict regulatory requirements. Docugami's AI-powered #DocumentEngineering can accelerate #clinicaltrial analysis and reporting, streamline new #documentcreation, and drive more accurate and more efficient #regulatory #compliance. Learn more: https://lnkd.in/gaDqHkbc #AIforLifeSciences #AIDocumentCreation #AIDrugDevelopment #AIDocuments

Are you looking for a configurable, cost-effective way to transform your adverse event detection process? Look no further! Dive into our insightful infographic to learn how our self-managed solution automates unstructured data analysis, minimizing redundancy and manual review, so you can focus on validating potential safety risks! #pharmacovigilance #drugsafety #patientsafety #pharma

The future of drug safety is proactive, not reactive. This article explores how AI and data are revolutionizing pharmacovigilance, helping us identify risks before they become problems to shape a safer healthcare industry. Learn more: https://lnkd.in/eDfUqSfW

In the world of #Pharmacovigilance, data quality isn’t just a requirement—it’s a lifeline. Poor data can slow down safety decisions and, ultimately, put patients at risk. On November 19 at 11:30 AM EST, join Chandra P., Senior Director of Customer Success at MaxisIT Inc., for a webinar designed to transform how you manage pharmacovigilance data. In this session, you’ll uncover: ✅ Deduplication and normalization techniques ✅ How AI is reshaping pharmacovigilance ✅ Real-world solutions for faster, more accurate safety monitoring Don't miss the chance to strengthen your pharmacovigilance processes with industry-leading insights! 📅 Save your seat now: https://hubs.ly/Q02QV23P0 #ClinicalData #DataQuality #DrugSafety #AIinPharma #ClinicalData #WebinarAlert #MaxisiT

The volume of scientific literature has grown significantly, highlighting the challenge of manual screening for pharmacovigilance. In 2000, PubMed indexed around 450,000 new articles, whereas by 2020, this number had risen to nearly 1.75 million annually, reflecting almost a fourfold increase in just two decades. Projections suggest this growth trend will continue, with advancements in global research and technology driving further increases. By 2040, if the current trajectory persists, annual publications could exceed 3 million articles, adding immense complexity to pharmacovigilance processes. This data underscores the critical need for automation in literature surveillance. To tackle these challenges, we’ve developed an advanced AI-based solution that transforms literature surveillance. By combining intelligent automation with industry expertise, our tool ensures precise ICSR identification, safety signal detection, and multilingual analysis—all while significantly reducing manual effort. This solution is designed to keep pace with the rapidly expanding scientific landscape, enabling safety teams to focus on critical decision-making and ensuring compliance with global standards. Interested in learning how this can streamline your pharmacovigilance operations? Let’s connect—reach out to me directly, and I’ll be happy to discuss further. #Pharmacovigilance #SafetyMonitoring #AIInnovation #LiteratureSurveillance